[HTML][HTML] Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney …

…, N Chopra, H Miyashita, T Mikami, H Ueyama… - Cardiovascular …, 2021 - Springer
Background Emerging evidence suggests that sodium-glucose cotransporter-2 (SGLT-2)
inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with …

[HTML][HTML] Gender difference is associated with severity of coronavirus disease 2019 infection: an insight from a meta-analysis

H Ueyama, T Kuno, H Takagi… - Critical care …, 2020 - journals.lww.com
Objectives: Coronavirus disease 2019 is a novel infection now causing pandemic around
the world. The gender difference in regards to the severity of coronavirus disease 2019 …

Meta-analysis evaluating the effects of renin-angiotensin-aldosterone system blockade on outcomes of heart failure with preserved ejection fraction

T Kuno, H Ueyama, T Fujisaki, A Briasouli… - The American journal of …, 2020 - Elsevier
Clinical trials of renin-angiotensin-aldosterone system (RAAS) antagonists in heart failure
with preserved ejection fraction (HFpEF) have suggested neutral results and treatment is …

Impact of surgical and transcatheter aortic valve replacement in low-gradient aortic stenosis: a meta-analysis

H Ueyama, T Kuno, M Harrington, H Takagi… - Cardiovascular …, 2021 - jacc.org
Objectives The aim of this study was to assess the impact of aortic valve replacement (AVR)
on survival in patients with each subclass of low-gradient (LG) aortic stenosis (AS) and to …

Prognostic value of left ventricular global longitudinal strain in mitral regurgitation: a systematic review

H Ueyama, T Kuno, H Takagi, P Krishnamoorthy… - Heart Failure …, 2023 - Springer
Conventional echocardiographic assessment may overestimate the left ventricular (LV) function
in mitral regurgitation (MR). LV global longitudinal strain (GLS) is more sensitive marker …

Comparison of intravascular imaging, functional, or angiographically guided coronary intervention

T Kuno, Y Kiyohara, A Maehara, HA Ueyama… - Journal of the American …, 2023 - jacc.org
Background In patients undergoing percutaneous coronary intervention (PCI), it remains
unclear whether intravascular imaging guidance or functional guidance is the best strategy to …

Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: a meta-analysis of randomized trials

T Kuno, H Ueyama, SV Rao, MG Cohen… - American Heart …, 2020 - Elsevier
We aimed to investigate long-term (≥5 years) outcomes of percutaneous coronary intervention
(PCI) versus coronary artery bypass grafting (CABG) for left main coronary artery disease …

Meta-analysis of antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

T Kuno, H Ueyama, H Takagi, T Ando… - The American journal of …, 2020 - Elsevier
For patients with atrial fibrillation (AF) who undergo percutaneous coronary intervention (PCI),
antithrombotic therapy including oral anticoagulants and antiplatelets are indicated. The …

Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists after transcatheter aortic valve implantation

H Ueyama, T Kuno, T Ando, A Briasoulis, J Fox… - The American Journal of …, 2020 - Elsevier
Atrial fibrillation (AF) is a common co-morbidity in patients undergoing transcatheter aortic
valve implantation (TAVI), but whether direct oral anticoagulants (DOACs) confer similar safety …

[HTML][HTML] Meta‐regression of COVID‐19 prevalence/fatality on socioeconomic characteristics of data from top 50 US large cities

H Takagi, T Kuno, Y Yokoyama, H Ueyama… - Journal of medical …, 2021 - ncbi.nlm.nih.gov
To the Editor, Reuters reported “The coronavirus mortality rate among some of the poorest
Catalans is five times higher than among the wealthiest residents of the Spanish region, a …